Non-targeted metabolomics for the identification of plasma metabolites associated with organic anion transporting polypeptide 1B1 function

被引:1
|
作者
Hamalainen, Kreetta [1 ,2 ]
Hirvensalo, Paeivi [1 ,2 ,3 ]
Neuvonen, Mikko [1 ,2 ]
Tornio, Aleksi [1 ,2 ,3 ,4 ]
Backman, Janne T. [1 ,2 ,5 ]
Lehtonen, Marko [6 ,7 ]
Niemi, Mikko [1 ,2 ,5 ,8 ]
机构
[1] Univ Helsinki, Dept Clin Pharmacol, Helsinki, Finland
[2] Univ Helsinki, Fac Med, Individualized Drug Therapy Res Program, Helsinki, Finland
[3] Univ Turku, Inst Biomed, Integrat Physiol & Pharmacol, Turku, Finland
[4] Turku Univ Hosp, Unit Clin Pharmacol, Turku, Finland
[5] Helsinki Univ Hosp, HUS Diagnost Ctr, Dept Clin Pharmacol, Helsinki, Finland
[6] Univ Eastern Finland, Fac Hlth Sci, Sch Pharm, Kuopio, Finland
[7] Bioctr Kuopio, LC MS Metabol Ctr, Kuopio, Finland
[8] Univ Helsinki, Dept Clin Pharmacol, POB 20, Helsinki 00014, Finland
来源
基金
欧洲研究理事会;
关键词
SLCO1B1; POLYMORPHISM; HAPLOTYPE RECONSTRUCTION; BILE-ACIDS; PHARMACOKINETICS; PHARMACOGENETICS; COPROPORPHYRINS; ATORVASTATIN; PRAVASTATIN; BIOMARKERS; VARIANTS;
D O I
10.1111/cts.13773
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Our aim was to evaluate biomarkers for organic anion transporting polypeptide 1B1 (OATP1B1) function using a hypothesis-free metabolomics approach. We analyzed fasting plasma samples from 356 healthy volunteers using non-targeted metabolite profiling by liquid chromatography high-resolution mass spectrometry. Based on SLCO1B1 genotypes, we stratified the volunteers to poor, decreased, normal, increased, and highly increased OATP1B1 function groups. Linear regression analysis, and random forest (RF) and gradient boosted decision tree (GBDT) regressors were used to investigate associations of plasma metabolite features with OATP1B1 function. Of the 9152 molecular features found, 39 associated with OATP1B1 function either in the linear regression analysis (p < 10-5) or the RF or GBDT regressors (Gini impurity decrease > 0.01). Linear regression analysis showed the strongest associations with two features identified as glycodeoxycholate 3-O-glucuronide (GDCA-3G; p = 1.2 x 10(-20) for negative and p = 1.7 x 10(-19) for positive electrospray ionization) and one identified as glycochenodeoxycholate 3-O-glucuronide (GCDCA-3G; p = 2.7 x 10(-16)). In both the RF and GBDT models, the GCDCA-3G feature showed the strongest association with OATP1B1 function, with Gini impurity decreases of 0.40 and 0.17. In RF, this was followed by one GDCA-3G feature, an unidentified feature with a molecular weight of 809.3521, and the second GDCA-3G feature. In GBDT, the second and third strongest associations were observed with the GDCA-3G features. Of the other associated features, we identified with confidence two representing lysophosphatidylethanolamine 22:5. In addition, one feature was putatively identified as pregnanolone sulfate and one as pregnenolone sulfate. These results confirm GCDCA-3G and GDCA-3G as robust OATP1B1 biomarkers in human plasma.
引用
收藏
页数:14
相关论文
共 50 条
  • [31] Amino-terminal region plays an important role in transport function of human organic anion transporting polypeptide 1B1
    Hong, Mei
    Chen, Jie
    Xiang, Zhaojian
    Fang, Zihui
    Ni, Chunxu
    FASEB JOURNAL, 2018, 32 (01):
  • [32] Leucine heptad motifs within transmembrane domains affect function and oligomerization of human organic anion transporting polypeptide 1B1
    Ni, Chunxu
    Wang, Xuyang
    Chen, Jie
    Xu, Su
    Ye, Wenjing
    Hong, Mei
    BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 2021, 1863 (04):
  • [33] IDENTIFICATION AND EVALUATION OF CLINICAL SUBSTRATES OF ORGANIC ANION TRANSPORTING POLYPEPTIDES 1B1 AND 1B3
    McFeely, Savannah J.
    Ritchie, Tasha K.
    Yu, Jingjing
    Berglund, Eva Gil
    Nordmark, Anna
    Ragueneau-Majlessi, Isabelle
    DRUG METABOLISM AND PHARMACOKINETICS, 2018, 33 (01) : S19 - S19
  • [34] Identification and Evaluation of Clinical Substrates of Organic Anion Transporting Polypeptides 1B1 and 1B3
    McFeely, Savannah J.
    Ritchie, Tasha K.
    Yu, Jingjing
    Nordmark, Anna
    Levy, Rene H.
    Ragueneau-Majlessi, Isabelle
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2019, 12 (04): : 379 - 387
  • [35] Organic anion transporting polypeptide 1B1 activity classified by SLCO1B1 genotype influences atrasentan pharmacokinetics
    Katz, DA
    Carr, R
    Grimm, DR
    Xiong, H
    Holley-Shanks, R
    Mueller, T
    Leake, B
    Wang, Q
    Han, LX
    Wang, PG
    Edeki, T
    Sahelijo, L
    Doan, T
    Allen, A
    Spear, BB
    Kim, RB
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2006, 79 (03) : 186 - 196
  • [36] How does S-palmitoylation affect the Organic Anion Transporting Polypeptide 1B1 (OATP1B1)?
    Villanueva, Cecilia E.
    Hagenbuch, Bruno
    FASEB JOURNAL, 2022, 36
  • [37] The effect of herbal medicine baicalin on pharmacokinetics of rosuvastatin, substrate of organic anion-transporting polypeptide 1B1
    Fan, L.
    Zhang, W.
    Guo, D.
    Tan, Z-R
    Xu, P.
    Li, Q.
    Liu, Y-Z
    Zhang, L.
    He, T-Y
    Hu, D-L
    Wang, D.
    Zhou, H-H
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2008, 83 (03) : 471 - 476
  • [38] Organic Anion Transporting Polypeptide 1B1: a Genetically Polymorphic Transporter of Major Importance for Hepatic Drug Uptake
    Niemi, Mikko
    Pasanen, Marja K.
    Neuvonen, Pertti J.
    PHARMACOLOGICAL REVIEWS, 2011, 63 (01) : 157 - 181
  • [39] Conserved Tryptophan Residues within Putative Transmembrane Domain 6 Affect Transport Function of Organic Anion Transporting Polypeptide 1B1
    Huang, Jiujiu
    Li, Nan
    Hong, Weifang
    Zhan, Kai
    Yu, Xuan
    Huang, Hong
    Hong, Mei
    MOLECULAR PHARMACOLOGY, 2013, 84 (04) : 521 - 527
  • [40] Inhibition of human organic anion transporting polypeptide OATP 1B1 as a mechanism of drug-induced hyperbilirubinemia
    Campbell, SD
    de Morais, SM
    Xu, JHJ
    CHEMICO-BIOLOGICAL INTERACTIONS, 2004, 150 (02) : 179 - 187